NCT06091527 Treating Major Depression With Yoga Mono-therapy
| NCT ID | NCT06091527 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Depression Mild |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-10-25 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-10-25 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.
Eligibility Criteria
Inclusion criteria: * 18 years of age or older * Able to give voluntary, informed consent * English-speaking * Diagnosis of clinical depression Exclusion criteria: * Current use of antidepressant medication * Current engagement in psychotherapy * Current pregnancy * Significant medical issues interfering with yoga practice
Contact & Investigator
Sudha Prathikanti, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06091527 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression Mild. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06091527 currently recruiting?
Yes, NCT06091527 is actively recruiting participants. Contact the research team at sudha.prathikanti@ucsf.edu for enrollment information.
Where is the NCT06091527 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT06091527 clinical trial?
NCT06091527 is sponsored by University of California, San Francisco. The principal investigator is Sudha Prathikanti, MD at University of California, San Francisco. The trial plans to enroll 180 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.